Tokyo, Japan

Sen-ichi Narita


Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Fukushima, JP (1983)
  • Tokyo, JP (1992)
  • Saitama, JP (1998)

Company Filing History:


Years Active: 1983-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Sen-ichi Narita

Introduction

Sen-ichi Narita is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 3 patents, Narita's work focuses on innovative solutions for circulatory organ-related diseases.

Latest Patents

Narita's latest patents include a substituted cyclic amine compound and its production process. This compound is represented by a specific general formula and is designed to prevent and treat various circulatory diseases such as hypertension and ischemic heart disease. Another notable patent is for cis-bicyclo[4,3.0]non-2-end derivatives, which also have potential therapeutic uses. These compounds demonstrate Narita's commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Throughout his career, Sen-ichi Narita has worked with prominent companies such as Toa Eiyo Ltd. and Sagami Chemical Research Center. His experience in these organizations has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to innovation.

Collaborations

Some of Narita's notable coworkers include Shin-ichi Yamada and Hiroyasu Sato. Their collaborative efforts have likely played a role in the successful development of his patented inventions.

Conclusion

Sen-ichi Narita's work exemplifies the spirit of innovation in the field of chemistry. His patents not only showcase his inventive capabilities but also contribute to the advancement of medical treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…